NCT01933672 Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01932372 Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01927341 Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT01925456 Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder Status COMPLETED Phase PHASE1
NCT01925274 A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT01924650 A Pharmacokinetic Study of Three Different Particle Sizes of PH-797804 Status WITHDRAWN Phase PHASE1
NCT01923389 Multiple Dose Study Of PF-05231023 In Obese Adult Subjects Status TERMINATED Phase PHASE1
NCT01920399 A Phase I Study to Assess the Safety, Tolerability and PK of Ceftazidime-Avibactam in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT01920061 A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC) Status COMPLETED Phase PHASE1
NCT01919996 PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients Status TERMINATED Phase PHASE2
NCT01918202 A Study To Evaluate The PDE10 Enzyme Occupancy Following A Single Dose Of PF-02545920 In Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01918176 Drug Interaction Study To Investigate The Potential Effect Of Proton Pump Inhibitor On The Pharmacokinetics Of Palbociclib (PD-0332991) Status COMPLETED Phase PHASE1
NCT01917214 A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival Status COMPLETED Phase N/A
NCT01914796 A Phase I Trial to Investigate the Safety and Tolerability of PF-06412562 Status COMPLETED Phase PHASE1
NCT01911273 A Study To Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 (A Monoclonal Antibody With Antiangiogenic Features) In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver Cancer Status TERMINATED Phase PHASE2
NCT01909453 Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma Status COMPLETED Phase PHASE3
NCT01906125 A Study To Establish The Equivalence Of 2 Palbociclib (PD-0332991) Formulations To The Intended Final Market Product Status COMPLETED Phase PHASE1
NCT01904747 Characterization Of The Effect Of Food On Palbociclib (PD-0332991) Absorption Status COMPLETED Phase PHASE1
NCT01903733 Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008 Status COMPLETED Phase NA
NCT01900899 Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children Status COMPLETED Phase PHASE3